Journal for ImmunoTherapy of Cancer (Apr 2022)
Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Apr 2022)